Prevention committee

Prevention committee

ESGO Prevention 2

The Prevention Committee was established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer. ESGO has set as its mission to improve the health and well-being of women with gynaecological cancers through prevention, research, excellence in care and education. The Prevention Committee is therefore one of the cornerstones to ensure the fulfilment of its mission.

The Chair of the Prevention Committee is Prof. Murat Gultekin.

Committee Goals

  • Facilitate systematic research, issue scientific publications, and disseminate findings in the prevention and treatment of pre-invasive diseases.
  • Raise public and governmental awareness and advocate about gynaecological cancers, their prevention and treatment through ENGAGe.
  • Collaborate with professional societies, patient advocacy organisations, policymakers and other stakeholders to advance gynaecological cancers prevention and care.
  • Contribute to cervical cancer elimination in Europe in line with the WHO elimination programme 2030. Decrease mortality and extend life of gynaecological cancer patients in line with the EU Beat the cancer plan.

Committee Structure

 Prevention Committee Chair: Murat Gultekin

 

 

 

 

 

 

Members:

 

 

 

 

Marc Arbyn, Laia Bruni, Livia Giordano, Mihaela Grigore, Elmar Joura, Vesna Kesic, Maria Kyrgiou, Patrick Petignat, Mario Preti, Jalid Sehouli, Icó Tóth, Andreas Ullrich, Alexandra Wagner, Ignacio Zapardiel

 

 

 

 

ENYGO fellows: Nicolo Bizzarri, Taja Bracic, Joana Kacperczyk-Bartnik, Natalia Rodriguez, Nadja Taumberger, Charalampos Theofanakis

Cooperation with key stakeholders

 

World Health Organization has launched ''Cervical Cancer Elimination Program'' on November 19, 2020.

The program asks the countries to vaccinate the girls under 15 years of age (90% coverage), to screen females by minimal two times when they are 35 and 45 (70%) coverage and to treat the lesions detected appropriately (in 90% of cases).

Modelling studies show that if all countries can implement the program until 2030 and can achieve these targets, there will be a 30% reduction in cervical cancer mortality by 2030 and the cervical cancer may be eliminated until the end of this century (namely incidence less than 4 \ 100.000).

 

ESGO Prevention committee has joined in to fulfil the WHO cervical cancer elimination strategy as a leading European actor in prevention.


Committee webinars

Upcoming webinars 2022:

 

Next Prevention webinar is expected for June 2022.

Stay tuned on our website and social media for more information!

You may see all recordings of our past webinars in the below section Past webinars.

All you need to do is to register to eAcademy, it is for free!

Enjoy our high quality up do date webinars.

Committee Publications

Publications 2021

 

  • ESGO/EFC/IFCPC/ESP Terminology for dimensions of cone after local conservative
    treatment for cervical intra-epithelial neoplasia and early invasive cervical cancer, M. Kyrgiou Accepted for publication in Lancet Oncology.
  • ESGO-ISSVD-EFC-ECSVD Consensus statement on the management of pre-invasive
    vulvar and vaginal disease, M. Preti (Accepted as joint publication in IJGC and LJGTD).
  • ESGO list of HPV assays that can be used for cervical cancer screening, M. Arbyn, M. Gultekin.
  • Gynaecologic oncology on the global health agenda: A wake-up call. Gynaecologic Oncology.
  • HPV Prevention and Control – the way forward, The Lancet (in process of publication)
  • Self-tests in pregnant women (in process of publication)
  • Accuracy and effectiveness of HPV RNA testing in cervical cancer screening: systematic review and meta-analysis (in process of publication)

 

Publications 2020
Publications 2019

European projects

RISCC: Risk-based Screening for Cervical Cancer

ESGO/ENGAGe is involved in the Horizon 2020 RISCC project.

Within the RISCC project ESGO / ENGAGe is responsible for the co-creation of the e-health/m-health platform for risk based cervical cancer screening and for the dissemination of the results to 12 ENGAGe member countries. This project is planned for five years and intended to terminate in 2025.

For more information about the ESGO/ENGAGe involvement please use the following link.

Events of our partners

Upcoming events:

2nd EFC Interactive Learning Webinar for Colposcopists

May 18, 2022

This webinar is organised in collaboration with the French Colposcopy Society and will take place on 18th May 2022 at 6.00 pm CET.

Register before 16th May on our website (link to website).

Here is the link to the webinar website, where participants can register:

https://efcolposcopy.eu/education/interactive-webinars/

 

 

Prevention Committee awards

Dr. Murat Gultekin was awarded the IGCS Distinguished Advocacy Award for his extensive and tireless efforts to unify advocacy NGOs throughout Europe, forming ENGAGe. As the leading founder of HPV DNA Screening, Mobile Trucks and Central Mammography Report Unit, cancer registry systems and community- based palliative care system he is partly responsible for major innovations in cancer screening in Turkey and around the world. For more info visit the IGCS website.